Import Alert 54-07 lets FDA detain any germanium product offered for human consumption without examining it, including bulk entries with no label. FDA links chronic germanium use to kidney injury and death. Products for semiconductor or other non-human uses can be released, and only firms on the Green List are exempt.
Listed on 54-07? Send us the product, intended use and shipment details. We review your options and prepare the request.
Get a 54-07 Case Review| Item | Import Alert 54-07 |
|---|---|
| Official title | DWPE of Germanium Supplements for Human Consumption |
| Scope | All germanium products for human consumption, including bulk |
| Charge | Section 402(a)(1), refusal under 801(a)(3); code POISONOUS |
| Exception | Non-human uses, such as semiconductors |
| Green List | Yes; one firm in Korea is listed |
| Green List contact | Importalerts2@fda.hhs.gov |
Details follow the current text of Import Alert 54-07, published March 5, 2026.
Also sold as GE-132 and GE-OXY-132.
Named in the alert.
Sold as an oxygen supplement.
Named in the alert.
Named in the alert.
Named in the alert.
Evidence that the product is for a use other than human consumption, such as semiconductor manufacturing, or private lab analysis of representative samples, sent to the FDA Division compliance office named in the notice. FDA may verify where the product goes.
Information showing the conditions behind the violation are resolved, sent to the Division of Import Operations through Importalerts2@fda.hhs.gov to be considered for the Green List, under RPM Chapter 9-8.
FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.
Removal help for food and supplements.
Supplement registration and labeling.
Supplements with hidden drugs.
Aristolochic acid in supplements.
Check claims and ingredient labeling.
FDA hold statuses and release steps.
We review the product and intended use, choose the right path and prepare the release or Green List request. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.
Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.
Get a 54-07 Case ReviewFDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.
Import Alert 54-07 is titled "Detention Without Physical Examination of Germanium Supplements for Human Consumption." It lets FDA detain germanium products offered for human consumption without examining each shipment.
FDA says germanium is a nonessential trace element that has caused kidney injury (nephrotoxicity) and death when used chronically by humans, even at recommended levels of use.
All germanium products offered for human consumption, including unlabeled bulk entries, except products on the Green List. Named examples include germanium sesquioxide, germanium-lactate-citrate, GE-132, GE-OXY-132, Vitamin "O", Pro-Oxygen, Nutrigel 132, Immune Multiple and Germax.
The product appears to contain a poisonous or deleterious substance that may render it injurious to health, making it adulterated under section 402(a)(1) and subject to refusal under section 801(a)(3). The OASIS code is POISONOUS.
No. The alert applies only to products for human consumption. If the importer shows the product is for another use, such as the semiconductor industry, the entry should be released, and FDA may follow up to verify where it goes.
It is product-wide. It applies to germanium products from all countries, unless the product is on the Green List.
The alert lists Geranti Pharmaceutical Ltd. in the Republic of Korea, for Geranti Bio-Germanium and Geranti Bio-Ge Yeast.
The owner or consignee can show the product is for a use other than human consumption, or provide private lab analysis of representative samples, sent to the FDA Division compliance office named in the notice. FDA may collect its own audit samples.
Send information showing the conditions behind the violation are resolved, so FDA can be confident future shipments will comply. The Division of Import Operations reviews requests case by case with FDA's food program. Email Importalerts2@fda.hhs.gov, following RPM Chapter 9-8.
Products whose labeling claims to diagnose, cure, mitigate, treat or prevent disease are referred to FDA's drug center under Import Alert 66-41. Supplements cannot make disease claims. See our dietary supplements page.
Germanium products for human consumption are detained under this alert unless they are on the Green List. Talk to us before importing any germanium ingredient for food or supplement use.
Green List requests go to Importalerts2@fda.hhs.gov. The alert lists the Division of Import Operations at (301) 796-0356 or Imports@fda.hhs.gov, FDAPRIVATELABIMPORTALERTS@fda.hhs.gov for analytical methods, and HFP-OCE-Imports@fda.hhs.gov for policy questions.
Importers must keep a Foreign Supplier Verification Program that covers germanium where it is a known or reasonably foreseeable hazard, with supplier verification and testing for higher-risk products. See our FSVP service.
No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.
Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.
Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.